Wealth Enhancement Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5M | Buy |
324,027
+12,427
| +4% | +$863K | 0.04% | 386 |
|
|
2025
Q1 | $22.9M | Buy |
311,600
+5,557
| +2% | +$408K | 0.04% | 359 |
|
|
2024
Q4 | $20.1M | Buy |
306,043
+114,302
| +60% | +$7.49M | 0.04% | 371 |
|
|
2024
Q3 | $14.9M | Buy |
191,741
+5,589
| +3% | +$435K | 0.03% | 416 |
|
|
2024
Q2 | $14.5M | Buy |
186,152
+4,551
| +3% | +$355K | 0.03% | 394 |
|
|
2024
Q1 | $12.3M | Buy |
181,601
+66,181
| +57% | +$4.48M | 0.03% | 414 |
|
|
2023
Q4 | $7.77M | Buy |
115,420
+49,474
| +75% | +$3.33M | 0.02% | 491 |
|
|
2023
Q3 | $4.47M | Buy |
+65,946
| New | +$4.47M | 0.01% | 611 |
|
|
2023
Q2 | – | Sell |
-3,569
| Closed | -$248K | – | 514 |
|
|
2023
Q1 | $248K | Buy |
+3,569
| New | +$248K | ﹤0.01% | 475 |
|